Acasti Pharma Ownership 2024 | Who Owns Acasti Pharma Now?

OverviewFinancials Chart

Institutional Ownership

0.00%

Insider Ownership

38.39%

Retail Ownership

61.61%

Institutional Holders

1.00

Acasti Pharma Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ADVISORY SERVICES NETWORK, LLC	-	-	-	-250	-100.00%	-	Jun 30, 2023

Acasti Pharma's largest institutional shareholder is ADVISORY SERVICES NETWORK, LLC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ADVISORY SERVICES NETWORK, LLC	-	-	-	-250	-100.00%	-	Jun 30, 2023

The largest Acasti Pharma shareholder by % of total assets is ADVISORY SERVICES NETWORK, LLC. The company owns 0.00 shares of Acasti Pharma (ACST), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ADVISORY SERVICES NETWORK, LLC	-	-	-	-250	-100.00%	-	Jun 30, 2023

As of Jun 30 2023, Acasti Pharma's largest institutional buyer is ADVISORY SERVICES NETWORK, LLC. The company purchased -0.25K stocks of ACST, valued at -.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ADVISORY SERVICES NETWORK, LLC	-	-	-	-250	-100.00%	-	Jun 30, 2023

As of Jun 30 2023, Acasti Pharma's biggest institutional seller is ADVISORY SERVICES NETWORK, LLC. The company sold -0.25K shares of ACST, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ADVISORY SERVICES NETWORK, LLC	-	-	-	-250	-100.00%	-	Jun 30, 2023

Acasti Pharma's largest sold out institutional shareholder by shares sold is ADVISORY SERVICES NETWORK, LLC, sold -0.25K shares, valued at -, as of undefined.

Acasti Pharma Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
FIDELITY CONCORD STREET TRUST	0.00%	146,784	-	-	Feb 29, 2024
FIDELITY CONCORD STREET TRUST	0.00%	18,348	-	-	Feb 29, 2024
FIDELITY CONCORD STREET TRUST	0.00%	3,058	-	-	Feb 29, 2024
Series Portfolios Trust	0.00%	72	-	-	Jan 31, 2024
Series Portfolios Trust	0.00%	12	-	-	Jan 31, 2024

Acasti Pharma's largest mutual fund holder by % of total assets is "FIDELITY CONCORD STREET TRUST", owning 146.78K shares, compromising 0.00% of its total assets.

Acasti Pharma Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Mar, 23	1	-
31 Dec, 22	1	-
30 Jun, 22	1	-50.00%
31 Mar, 22	2	100.00%
31 Dec, 21	1	-50.00%
30 Sep, 21	2	-89.47%
30 Jun, 21	19	-
31 Mar, 21	19	-20.83%
31 Dec, 20	24	33.33%
30 Sep, 20	18	-18.18%
30 Jun, 20	22	-4.35%
31 Mar, 20	23	-28.13%
31 Dec, 19	32	28.00%
30 Sep, 19	25	108.33%
30 Jun, 19	12	9.09%
31 Mar, 19	11	-
31 Dec, 18	11	57.14%
30 Sep, 18	7	-36.36%
30 Jun, 18	11	-
31 Mar, 18	11	-
31 Dec, 17	11	37.50%
30 Sep, 17	8	33.33%
30 Jun, 17	6	50.00%
31 Mar, 17	4	-42.86%
31 Dec, 16	7	-
30 Sep, 16	7	-
30 Jun, 16	7	-22.22%
31 Mar, 16	9	-
31 Dec, 15	9	-

As of 31 Mar 23, 1 institutions are holding Acasti Pharma's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Mar, 23	250	-
31 Dec, 22	250	-
30 Jun, 22	5,000	-71.43%
31 Mar, 22	17,500	250.00%
31 Dec, 21	5,000	-71.43%
30 Sep, 21	17,500	-99.48%
30 Jun, 21	3,333,981	49.75%
31 Mar, 21	2,226,407	-46.28%
31 Dec, 20	4,144,250	233.08%
30 Sep, 20	1,244,229	-53.57%
30 Jun, 20	2,679,662	66.62%
31 Mar, 20	1,608,263	-68.61%
31 Dec, 19	5,124,260	45.25%
30 Sep, 19	3,527,912	40.08%
30 Jun, 19	2,518,543	4.59%
31 Mar, 19	2,408,127	-11.25%
31 Dec, 18	2,713,411	576.02%
30 Sep, 18	401,383	-67.55%
30 Jun, 18	1,237,072	145.63%
31 Mar, 18	503,630	-68.84%
31 Dec, 17	1,616,069	209.11%
30 Sep, 17	522,816	-2.12%
30 Jun, 17	534,125	8.42%
31 Mar, 17	492,658	-5.66%
31 Dec, 16	522,199	-8.34%
30 Sep, 16	569,686	6.30%
30 Jun, 16	535,947	-6.98%
31 Mar, 16	576,146	2.80%
31 Dec, 15	560,478	-

Acasti Pharma (ACST) has 250.00 shares outstanding as of 31 Mar 23, up 0.00% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Mar, 23	0.00%	166666.67%
31 Dec, 22	0.00%	-
30 Jun, 22	0.01%	722.78%
31 Mar, 22	0.04%	30973.45%
31 Dec, 21	0.01%	396.07%
30 Sep, 21	0.05%	2.09%
30 Jun, 21	1.60%	140.15%
31 Mar, 21	1.07%	7.59%
31 Dec, 20	3.75%	219.25%
30 Sep, 20	1.31%	14.98%
30 Jun, 20	2.95%	81.72%
31 Mar, 20	1.90%	5.44%
31 Dec, 19	5.91%	32.79%
30 Sep, 19	4.25%	41.39%
30 Jun, 19	3.20%	34.15%
31 Mar, 19	3.06%	20.86%
31 Dec, 18	3.83%	319.42%
30 Sep, 18	1.10%	7.25%
30 Jun, 18	3.89%	155.25%
31 Mar, 18	1.58%	1.41%
31 Dec, 17	10.61%	84.14%
30 Sep, 17	3.55%	26.94%
30 Jun, 17	3.63%	45.74%
31 Mar, 17	2.82%	11.85%
31 Dec, 16	4.87%	17.24%
30 Sep, 16	5.32%	21.25%
30 Jun, 16	5.00%	17.29%
31 Mar, 16	5.38%	19.65%
31 Dec, 15	5.23%	-

As of 31 Mar 23, Acasti Pharma is held by 0.00% institutional shareholders, representing a 166666.67% growth compared to 31 Dec 22.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Mar, 23	-	-100.00%
31 Dec, 22	1	-
30 Jun, 22	-	-100.00%
31 Mar, 22	1	-
31 Dec, 21	-	-
30 Sep, 21	-	-100.00%
30 Jun, 21	9	12.50%
31 Mar, 21	8	-50.00%
31 Dec, 20	16	300.00%
30 Sep, 20	4	-33.33%
30 Jun, 20	6	-50.00%
31 Mar, 20	12	-47.83%
31 Dec, 19	23	35.29%
30 Sep, 19	17	183.33%
30 Jun, 19	6	-14.29%
31 Mar, 19	7	-12.50%
31 Dec, 18	8	300.00%
30 Sep, 18	2	-71.43%
30 Jun, 18	7	75.00%
31 Mar, 18	4	-42.86%
31 Dec, 17	7	75.00%
30 Sep, 17	4	100.00%
30 Jun, 17	2	-
31 Mar, 17	-	-100.00%
31 Dec, 16	2	-50.00%
30 Sep, 16	4	100.00%
30 Jun, 16	2	-50.00%
31 Mar, 16	4	-55.56%
31 Dec, 15	9	-

- institutional shareholders have increased their position in ACST stock as of 31 Mar 23 compared to 1 in the previous quarter (a -100.00% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Mar, 23	-	-
31 Dec, 22	-	-
30 Jun, 22	-	-
31 Mar, 22	-	-
31 Dec, 21	-	-100.00%
30 Sep, 21	2	-50.00%
30 Jun, 21	4	300.00%
31 Mar, 21	1	-
31 Dec, 20	1	-83.33%
30 Sep, 20	6	100.00%
30 Jun, 20	3	-40.00%
31 Mar, 20	5	25.00%
31 Dec, 19	4	33.33%
30 Sep, 19	3	-
30 Jun, 19	3	-
31 Mar, 19	-	-100.00%
31 Dec, 18	1	-50.00%
30 Sep, 18	2	-
30 Jun, 18	-	-100.00%
31 Mar, 18	3	50.00%
31 Dec, 17	2	100.00%
30 Sep, 17	1	-
30 Jun, 17	1	-
31 Mar, 17	1	-75.00%
31 Dec, 16	4	-
30 Sep, 16	-	-100.00%
30 Jun, 16	2	-
31 Mar, 16	2	-
31 Dec, 15	-	-

- institutional shareholders have reduced their position in ACST stock as of 31 Mar 23 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Mar, 23	1	-	250	-	0.00%	166666.67%	-	-100.00%	-	-
31 Dec, 22	1	-	250	-	0.00%	-	1	-	-	-
30 Jun, 22	1	-50.00%	5,000	-71.43%	0.01%	722.78%	-	-100.00%	-	-
31 Mar, 22	2	100.00%	17,500	250.00%	0.04%	30973.45%	1	-	-	-
31 Dec, 21	1	-50.00%	5,000	-71.43%	0.01%	396.07%	-	-	-	-100.00%
30 Sep, 21	2	-89.47%	17,500	-99.48%	0.05%	2.09%	-	-100.00%	2	-50.00%
30 Jun, 21	19	-	3,333,981	49.75%	1.60%	140.15%	9	12.50%	4	300.00%
31 Mar, 21	19	-20.83%	2,226,407	-46.28%	1.07%	7.59%	8	-50.00%	1	-
31 Dec, 20	24	33.33%	4,144,250	233.08%	3.75%	219.25%	16	300.00%	1	-83.33%
30 Sep, 20	18	-18.18%	1,244,229	-53.57%	1.31%	14.98%	4	-33.33%	6	100.00%
30 Jun, 20	22	-4.35%	2,679,662	66.62%	2.95%	81.72%	6	-50.00%	3	-40.00%
31 Mar, 20	23	-28.13%	1,608,263	-68.61%	1.90%	5.44%	12	-47.83%	5	25.00%
31 Dec, 19	32	28.00%	5,124,260	45.25%	5.91%	32.79%	23	35.29%	4	33.33%
30 Sep, 19	25	108.33%	3,527,912	40.08%	4.25%	41.39%	17	183.33%	3	-
30 Jun, 19	12	9.09%	2,518,543	4.59%	3.20%	34.15%	6	-14.29%	3	-
31 Mar, 19	11	-	2,408,127	-11.25%	3.06%	20.86%	7	-12.50%	-	-100.00%
31 Dec, 18	11	57.14%	2,713,411	576.02%	3.83%	319.42%	8	300.00%	1	-50.00%
30 Sep, 18	7	-36.36%	401,383	-67.55%	1.10%	7.25%	2	-71.43%	2	-
30 Jun, 18	11	-	1,237,072	145.63%	3.89%	155.25%	7	75.00%	-	-100.00%
31 Mar, 18	11	-	503,630	-68.84%	1.58%	1.41%	4	-42.86%	3	50.00%
31 Dec, 17	11	37.50%	1,616,069	209.11%	10.61%	84.14%	7	75.00%	2	100.00%
30 Sep, 17	8	33.33%	522,816	-2.12%	3.55%	26.94%	4	100.00%	1	-
30 Jun, 17	6	50.00%	534,125	8.42%	3.63%	45.74%	2	-	1	-
31 Mar, 17	4	-42.86%	492,658	-5.66%	2.82%	11.85%	-	-100.00%	1	-75.00%
31 Dec, 16	7	-	522,199	-8.34%	4.87%	17.24%	2	-50.00%	4	-
30 Sep, 16	7	-	569,686	6.30%	5.32%	21.25%	4	100.00%	-	-100.00%
30 Jun, 16	7	-22.22%	535,947	-6.98%	5.00%	17.29%	2	-50.00%	2	-
31 Mar, 16	9	-	576,146	2.80%	5.38%	19.65%	4	-55.56%	2	-
31 Dec, 15	9	-	560,478	-	5.23%	-	9	-	-	-

Acasti Pharma Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Sep 27, 2023	Kavuru Vimal	director, 10 percent owner		P-Purchase	Buy	676,371	$1.85	$1.25M	1,188,076
Sep 27, 2023	Kavuru Vimal	director, 10 percent owner		P-Purchase	Buy	422,732	$3.00	$1.27M	422,732

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Sep 27, 2023	Kavuru Vimal	director, 10 percent owner		P-Purchase	Buy	676,371	$1.85	$1.25M	1,188,076
Sep 27, 2023	Kavuru Vimal	director, 10 percent owner		P-Purchase	Buy	422,732	$3.00	$1.27M	422,732

Insider Sells

Date	Name	Relation	Role	Buy/Sell	Shares	Price	Value	Shares Held
Jan 08, 2024	DelAversano Robert J	officer	Vice President, Finance	Sell	42,000	$2.13	$89.25K	-
Oct 20, 2023	Kottayil George	director	-	Sell	-	-	-	370,354
Oct 20, 2023	NEUGEBOREN EDWARD	director	-	Sell	-	-	-	37,895

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jul 11, 2024	ADAR1 Capital Management, LLC	10 percent owner	-		Buy	1,268,195	$3.00	$3.81M	-
Jul 11, 2024	ADAR1 Capital Management, LLC	10 percent owner	-		Buy	913,631	-	$91.36	-
Jul 09, 2024	ADAR1 Capital Management, LLC	10 percent owner	-		Buy	-	-	-	959,571
May 08, 2024	D'Andrea Carrie	officer	VP Program Management	A-Award	Buy	19,740	$2.96	$58.43K	19,740
May 08, 2024	Kumar Amresh	officer	VP Clinical Operations	A-Award	Buy	19,740	$2.96	$58.43K	19,740
May 08, 2024	Macdonald R. Loch	officer	Chief Medical Officer	A-Award	Buy	25,380	$2.96	$75.12K	25,380
May 08, 2024	DelAversano Robert J	officer	Principal Financial Officer	A-Award	Buy	4,500	$2.96	$13.32K	4,500
May 08, 2024	Kohli Prashant	director, officer	Chief Executive Officer	A-Award	Buy	128,770	$2.96	$381.16K	128,770
Jan 08, 2024	DelAversano Robert J	officer	Vice President, Finance		Sell	42,000	$2.13	$89.25K	-
Dec 20, 2023	Kavuru Vimal	director, 10 percent owner		A-Award	Buy	10,000	$2.13	$21.25K	10,000
Dec 20, 2023	Kottayil George	director	-	A-Award	Buy	22,500	$2.13	$47.81K	22,500
Dec 20, 2023	NEUGEBOREN EDWARD	director	-	A-Award	Buy	22,500	$2.13	$47.81K	22,500
Dec 20, 2023	DAVIS A BRIAN	director	-	A-Award	Buy	22,500	$2.13	$47.81K	22,500
Dec 20, 2023	Kohli Prashant	director, officer	Chief Executive Officer	A-Award	Buy	41,668	$2.13	$88.54K	41,668
Oct 20, 2023	Kottayil George	director	-		Sell	-	-	-	370,354
Oct 20, 2023	Kottayil George	director	-		Buy	-	-	-	124,344
Oct 20, 2023	NEUGEBOREN EDWARD	director	-		Sell	-	-	-	37,895
Oct 20, 2023	DAVIS A BRIAN	director			Buy	-	-	-	-
Sep 27, 2023	Kavuru Vimal	director, 10 percent owner		P-Purchase	Buy	676,371	$1.85	$1.25M	1,188,076
Sep 27, 2023	Kavuru Vimal	director, 10 percent owner		P-Purchase	Buy	422,732	$3.00	$1.27M	422,732

The last insider sell of Acasti Pharma's stock was made by DelAversano Robert J on Jan 08 2024, selling 42,000 shares at $2.13 per share (valued at $89.25K). The last insider buy of ACST was made by Kavuru Vimal on Sep 27 2023, buying 676,371 shares at $1.85 per share (worth $1.25M).

Acasti Pharma Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	5	-	-
Q1 2024	-	1	-
Q4 2023	5	2	250.00%
Q3 2023	10	-	-
Q2 2023	-	1	-
Q3 2022	4	3	133.33%
Q2 2022	4	-	-
Q1 2022	-	-	-
Q4 2021	9	2	450.00%
Q3 2021	-	2	-
Q3 2020	-	-	-
Q2 2020	-	18	-
Q1 2017	-	3	-

5 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Acasti Pharma's insiders, as of Q2 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	-	-	-
Q1 2024	-	-	-
Q4 2023	-	-	-
Q3 2023	3	-	-
Q2 2023	-	-	-
Q3 2022	-	-	-
Q2 2022	-	-	-
Q1 2022	-	-	-
Q4 2021	-	-	-
Q3 2021	-	-	-
Q3 2020	-	-	-
Q2 2020	-	-	-
Q1 2017	-	-	-

As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Acasti Pharma's stocks.

Acasti Pharma Peer Ownership

Ticker	Company
GOVX	GeoVax Labs, Inc.
ARDS	Aridis Pharmaceuticals, Inc.
PULM	Pulmatrix, Inc.
ABVC	ABVC BioPharma, Inc.
BPTH	Bio-Path Holdings, Inc.
ADTX	Aditxt, Inc.
TNXP	Tonix Pharmaceuticals Holding Corp.
DFFN	CervoMed Inc.
AKTX	Akari Therapeutics, Plc
JAGX	Jaguar Health, Inc.
MBRX	Moleculin Biotech, Inc.
ONTX	Traws Pharma, Inc.
CBIO	Gyre Therapeutics, Inc.
OCGN	Ocugen, Inc.

ACST Ownership FAQ

Who Owns Acasti Pharma?

Acasti Pharma is owned by institutional shareholders (0.00%), insiders (38.39%), and public (61.61%). The largest institutional shareholder of Acasti Pharma is ADVISORY SERVICES NETWORK, LLC (0% of total shares) and the top mutual fund owner is FIDELITY CONCORD STREET TRUST (0.00% of total shares).

Who are the major institutional shareholders of Acasti Pharma?

Acasti Pharma's major institutional shareholders are ADVISORY SERVICES NETWORK, LLC. The top five shareholders own together 0% of the company's share outstanding.

How many Acasti Pharma shareholders are there?

As of Mar 2023, there are 1 institutional shareholders of Acasti Pharma.

What percentage of Acasti Pharma is owned by ADVISORY SERVICES NETWORK, LLC?

ADVISORY SERVICES NETWORK, LLC owns 0 shares of Acasti Pharma, representing 0% of the company's total shares outstanding, valued at $0 (as of Jun 2023).